Total Raised

$106.5M

Investors Count

14

Deal Terms

3

Investments

1

Funding, Valuation & Revenue

7 Fundings

Science 37 has raised $106.5M over 7 rounds.

Science 37's latest funding round was a Take Private for on March 12, 2024.

Science 37's latest post-money valuation is from March 2024.

Sign up for a free demo to see Science 37's valuations in March 2024 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/12/2024

Take Private

$XXM

0

FY undefined

4

10/7/2021

Reverse Merger

$XXM

0

FY undefined

10

8/20/2020

Series D - II

$XXM

$XXM

0

FY undefined

10

3/1/2019

Series D

$XXM

0

FY undefined

0

4/25/2017

Series C

$XXM

$XXM

0

FY undefined

10

Date

3/12/2024

10/7/2021

8/20/2020

3/1/2019

4/25/2017

Round

Take Private

Reverse Merger

Series D - II

Series D

Series C

Amount

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

4

10

10

0

10

Start free trial
New call-to-action

Science 37 Deal Terms

3 Deal Terms

Science 37's deal structure is available for 3 funding rounds, including their Take Private from March 12, 2024.

Round

Take Private

Series B

Series A

Funding Date

$XXM

$XXM

$XXM

Pre-Money Valuation

Post-Money Valuation

$XXM

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

$XXM

Board Voting

$XXM

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Take Private

$XXM

$XXM

$XXM

$XXM

Series B

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

Science 37 Investors

14 Investors

Science 37 has 14 investors. eMed invested in Science 37's Take Private funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

3/12/2024

3/12/2024

1
Take Private

Corporation

Massachusetts

10/7/2021

10/7/2021

1
Reverse Merger

SPAC

New York

10/20/2015

8/20/2020

5
Series A, Series B (2016), Series C (2017), Series D (2019), Series D - II (2020)

Venture Capital

Switzerland

00/00/0000

00/00/0000

Lux Capital

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

Redmile Group

Subscribe to see more

Subscribe to see more

Hedge Fund

California

First funding

3/12/2024

10/7/2021

10/20/2015

00/00/0000

00/00/0000

Last Funding

3/12/2024

10/7/2021

8/20/2020

00/00/0000

00/00/0000

Investor

Lux Capital

Redmile Group

Rounds

1
Take Private
1
Reverse Merger
5
Series A, Series B (2016), Series C (2017), Series D (2019), Series D - II (2020)

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Corporation

SPAC

Venture Capital

Venture Capital

Hedge Fund

Location

Massachusetts

New York

Switzerland

New York

California

Science 37 Investments

1 Investments

Science 37 has made 1 investments. Their latest investment was in Lindus Health as part of their Series A on August 16, 2023.

CBI Logo

Science 37 Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/16/2023

Series A

Lindus Health

$18M

Yes

Creandum, Curebase, Florence Healthcare, Koneksa Health, Peter Thiel, Seedcamp, and Undisclosed Investors

1

Date

8/16/2023

Round

Series A

Company

Lindus Health

Amount

$18M

New?

Yes

Co-Investors

Creandum, Curebase, Florence Healthcare, Koneksa Health, Peter Thiel, Seedcamp, and Undisclosed Investors

Sources

1

New call-to-action

Compare Science 37 to Competitors

Medable Logo
Medable

Medable specializes in the development of decentralized clinical trial software and electronic Clinical Outcome Assessment (eCOA) solutions within the healthcare technology sector. The company's platform provides tools for remote monitoring, data collection, and trial management, utilizing artificial intelligence (AI) to improve processes in clinical research. Medable serves the pharmaceutical and biotechnology industries, including mid to large pharma, emerging biotech firms, and contract research organizations (CROs). Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.

Castor Logo
Castor

Castor operates within the healthcare sector and provides a clinical trial platform designed for the design, deployment, patient engagement, data collection, and analysis of clinical trials. The platform is adaptable and can meet the requirements of different stakeholders in the clinical research process. It primarily serves the healthcare sector. The company was founded in 2012 and is based in Amsterdam, Netherlands.

Curebase Logo
Curebase

Curebase is a company that provides an eClinical platform in the clinical research sector, offering tools such as electronic patient-reported outcomes (ePRO), electronic clinical outcome assessments (eCOA), electronic consent (eConsent), and electronic data capture (EDC) systems. The platform is designed for study launches, data collection, and participant engagement. It was founded in 2017 and is based in San Francisco, California.

ObvioHealth Logo
ObvioHealth

ObvioHealth is a digital health organization focused on improving clinical trials through technology. The company offers a platform for conducting decentralized and hybrid clinical trials, providing services such as study design, participant recruitment, electronic consent and enrollment, data capture and monitoring, and analytics and reporting. ObvioHealth serves the healthcare sectors, including CROs, medical devices, pharmaceuticals, biotechnology, and consumer health industries. It was founded in 2017 and is based in New York, New York.

Reify Health Logo
Reify Health

Reify Health provides digital solutions and infrastructure within the healthcare and pharmaceutical sectors to support the clinical trials ecosystem. The company offers cloud-based software aimed at trial enrollment processes and supplies the infrastructure required for clinical research. Reify Health serves biopharma companies, research clinics, and healthcare and community organizations. Reify Health was formerly known as ZeroSum Health. It was founded in 2012 and is based in Boston, Massachusetts.

Evidation Logo
Evidation

Evidation is involved in measuring health in everyday life within the digital health sector. The company provides a platform for individuals to track health activities, participate in research, and manage their data privacy. Evidation serves the life sciences, government, and non-profit organizations. It was founded in 2012 and is based in San Mateo, California.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.